{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:40:01Z","timestamp":1750099201707,"version":"3.41.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>An 84-year-old woman presented with a 3-month history of a papular rash on the trunk, abdomen, and back. Histopathological examination revealed atypical lymphoid deep and band-like dermal infiltrates with marked epidermotropism. Neoplastic cells expressed B-cell markers (CD20), and clonal immunoglobulin gene rearrangement was observed. A complete peripheral blood study revealed aberrant circulating villous lymphocytes with the expression of B-cell markers (CD20, CD22, and CD79a) and aberrant expression of CD5. A staging workup revealed discrete splenic enlargement and bone marrow and gastrointestinal tract involvement. Skin lesions regressed spontaneously several weeks after diagnosis. Throughout evolution, the patient developed scattered cutaneous nodules and generalized papulo-nodules showing either epidermotropic or nonepidermotropic atypical dermal lymphoid infiltrates. This case illustrates the observation of autoinvolutive and recurrent epidermotropic B-cell atypical cutaneous infiltrates as a characteristic feature of secondary cutaneous involvement in splenic marginal B-cell lymphoma. Previously reported cases of epidermotropic B-cell lymphoma have been reviewed. Concurrent and simultaneous observation of epidermotropic and nonepidermotropic lesions seems to indicate that epidermotropism is an important but nonconstant diagnostic feature of splenic marginal B-cell lymphoma.<\/jats:p>","DOI":"10.1097\/dad.0000000000002329","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T04:46:32Z","timestamp":1674276392000},"page":"81-85","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Epidermotropic B-Cell Lymphoma: A Case of Secondary Cutaneous Splenic Marginal Zone B-Cell Lymphoma With Autoinvolutive and Recurrent Cutaneous Lesions"],"prefix":"10.1097","volume":"45","author":[{"given":"Roger","family":"Rovira-L\u00f3pez","sequence":"first","affiliation":[{"name":"Department of Dermatology, Parc de Salut Mar, Barcelona, Spain;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Gallardo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Parc de Salut Mar, Barcelona, Spain;"},{"name":"Universitat Aut\u00f2noma, Barcelona, Spain;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Salar","sequence":"additional","affiliation":[{"name":"Universitat Aut\u00f2noma, Barcelona, Spain;"},{"name":"Department of Hematology, Parc de Salut Mar, Barcelona, Spain;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lluis","family":"Colomo","sequence":"additional","affiliation":[{"name":"Universitat Aut\u00f2noma, Barcelona, Spain;"},{"name":"Department of Pathology and Cytology, Parc de Salut Mar, Barcelona, Spain; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon M.","family":"Pujol","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Parc de Salut Mar, Barcelona, Spain;"},{"name":"Universitat Pompeu Fabra, Barcelona, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/jdv.13217","article-title":"Epidermotropic diffuse large B-cell lymphoma infiltrating the umbilicus, presenting as Sister Mary Joseph's nodule","volume":"30","author":"Furudate","year":"2016","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00000372-199712000-00001","article-title":"Evaluation of classic architectural criteria in non-mycosis fungoides cutaneous lymphomas","volume":"19","author":"Glusac","year":"1997","journal-title":"Am J Dermatopathology"},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0190-9622(95)91430-7","article-title":"A clinical and histologic mycosis fungoides simulant occurring as a T-cell infiltrate coexisting with B-cell leukemia cutis","volume":"33","author":"Metzman","year":"1995","journal-title":"J Am Acad Dermatol."},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/DAD.0000000000001718","article-title":"Epidermotropic epstein\u2013barr virus-positive diffuse large B-cell lymphoma: a series of 3 cases of a very unusual high-grade lymphoma","volume":"43","author":"Wu","year":"2021","journal-title":"Am J Dermatopathology"},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0190-9622(92)70036-F","article-title":"Primary B-cell lymphoma with histologic features of a T-cell neoplasm","volume":"26","author":"Landa","year":"1992","journal-title":"J Am Acad Dermatol."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.blre.2004.03.002","article-title":"Splenic marginal zone lymphoma","volume":"19","author":"Oscier","year":"2005","journal-title":"Blood Rev."},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/DAD.0000000000000055","article-title":"Rare presentation of secondary cutaneous involvement by splenic marginal zone lymphoma","volume":"37","author":"Cohen","year":"2015","journal-title":"Am J Dermatopathology"},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0190-9622(99)70063-0","article-title":"Epidermotropic cutaneous B-cell lymphoma mimicking mycosis fungoides","volume":"41","author":"Chui","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1468-3083.2007.02522.x","article-title":"Primary cutaneous epidermotropic marginal zone B-cell lymphoma: a role for antihistamines in maintaining lymphoma cell growth?","volume":"22","author":"Pavlovic","year":"2008","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jaad.2009.02.032","article-title":"Cutaneous B-cell lymphoma with histologic features of mycosis fungoides","volume":"62","author":"Chiang","year":"2010","journal-title":"J Am Acad Dermatol."},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ad.2011.06.004","article-title":"Linfoma B espl\u00e9nico de la zona marginal con afectaci\u00f3n cut\u00e1nea epidermotropa","volume":"103","author":"G\u00f3mez-de la Fuente","year":"2012","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas."},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/cup.12862","article-title":"Epidermotropic skin involvement of splenic marginal zone B-cell lymphoma: a diagnostic challenge","volume":"44","author":"Baykal","year":"2017","journal-title":"J Cutan Pathol."},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/cup.13116","article-title":"Epidermotropic presentation by splenic B-cell lymphoma: the importance of clinical-pathologic correlation","volume":"45","author":"Hedayat","year":"2018","journal-title":"J Cutan Pathol."},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2559.2002.01314.x","article-title":"Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?","volume":"40","author":"Mollejo","year":"2002","journal-title":"Histopathology"},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2340\/00015555-2981","article-title":"Remission of cutaneous involvement in splenic marginal zone lymphoma after splenectomy","volume":"98","author":"Mai","year":"2018","journal-title":"Acta Derm Venereol."},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/cup.12114","article-title":"Epidermotropic marginal zone lymphoma simulating mycosis fungoides\u2020","volume":"40","author":"Lee","year":"2013","journal-title":"J Cutan Pathol."},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/DAD.0000000000000401","article-title":"Epidermotropic B-cell lymphoma","volume":"38","author":"Magro","year":"2016","journal-title":"Am J Dermatopathology"},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jdcr.2017.06.024","article-title":"Epidermotropic marginal zone lymphoma: an uncommon cutaneous B-cell lymphoma responsive to rituximab","volume":"3","author":"Magro","year":"2017","journal-title":"JAAD Case Rep."},{"key":"R21-20250616","doi-asserted-by":"crossref","DOI":"10.5070\/D3257044803","article-title":"Epidermotropic CXCR3 positive marginal zone lymphoma: a distinctive clinical histopathological entity potentially originating in the skin; it does not always indicate splenic marginal zone lymphoma","volume":"25","author":"Magro","year":"2019","journal-title":"Dermatol Online J."},{"key":"R22-20250616","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jdcr.2021.06.027","article-title":"Primary cutaneous epidermotropic marginal zone B-cell lymphoma treated with total skin electron beam therapy","volume":"15","author":"Boudreaux","year":"2021","journal-title":"JAAD Case Rep."},{"key":"R23-20250616","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol."},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archderm.141.9.1139","article-title":"Primary cutaneous marginal zone B-cell lymphoma","volume":"141","author":"Hoefnagel","year":"2005","journal-title":"Arch Dermatol."},{"key":"R26-20250616","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/labinvest.3780248","article-title":"CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells","volume":"81","author":"Garc\u00eda-L\u00f3pez","year":"2001","journal-title":"Lab Invest."},{"key":"R27-20250616","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V95.2.627","article-title":"The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia","volume":"95","author":"Jones","year":"2000","journal-title":"Blood"},{"key":"R28-20250616","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ijc.20823","article-title":"CXCR3-positive B cells found at elevated frequency in the peripheral blood of patients with MALT lymphoma are attracted by MIG and belong to the lymphoma clone","volume":"114","author":"Suefuji","year":"2005","journal-title":"Int J Cancer"},{"key":"R29-20250616","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/1042819031000060546","article-title":"Expression of chemokine receptor CXCR3 and its ligand, Mig, in gastric and thyroid marginal zone lymphomas. Possible migration and autocrine Mechanism","volume":"44","author":"Ohshima","year":"2003","journal-title":"Leuk Lymphoma"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:05:28Z","timestamp":1750097128000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002329","relation":{},"ISSN":["0193-1091"],"issn-type":[{"type":"print","value":"0193-1091"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"assertion":[{"value":"2022-07-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}